ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

An “insurgency” targets randomized trials, demands access to investigational drugs.

August 5, 2005

Kimmel Foundation To Donate $1 million for Cancer Research

June 28, 1996

US Oncology Renegotiates Affiliations, Converts Practices To Earnings Model.

November 30, 2001

NIH Changes SBIR/STTG Application Receipt Dates.

February 18, 2000

BMS Award Honors Jordan; Matthews Media Wins $23 Million Contract From MCI.

April 6, 2001

NCI Will Get $1.3 Billion, But Only If Congress Fends Off GRH Cuts, Reprogramming For Drug War

October 3, 1986